Skip to main content
OpenTrials
Completed

NCT Number: NCT00411177

Comparison of Post-dilution On-line Hemodiafiltration and Hemodialysis

This study aims to compare high-efficiency post-dilution on-line hemodiafiltration and high-flux hemodialysis regarding mortality, hospitalization rate, several clinical and laboratory parameters, and required medications.

The investigators hypothesize that high-efficiency post-dilution on-line hemodiafiltration may provide better outcome, less morbidity, higher quality of life, and lesser requirement of medications.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The proposed controlled, randomized study aims to compare high-efficiency post-dilution on-line hemodiafiltration and high-flux hemodialysis regarding mortality, hospitalization rate, several clinical and laboratory parameters, and required medications.

Seven hundred and eighty HD patients will be taken into the study. The study will last for two years with an intermediate analysis at the first year. The patients will be randomly placed in two groups:

  • Post-dilution on-line hemodiafiltration,
  • High-flux hemodialysis.

In both groups, FX series high-flux helixone membranes will be used, duration of each session 240 minutes, and blood flow rates 250-400 ml/min. ONLINEplus integrated Fresenius 4008S machines will be used for on-line post-dilution HDF. Substitution volume will be above 15 liters in hemodiafiltration sessions.

Echocardiography for determination of left ventricular geometry, pulse wave velocity analysis to assess arterial stiffness, evaluation of nutritional and inflammatory state, assessment of life quality, depression and cost analysis will be performed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • older than 18 years
  • on maintenance bicarbonate HD scheduled thrice weekly 12 hours/week,achieved mean single pool Kt/V above 1.2
  • willingness to participate in the study with a written informed consent

Exclusion criteria

  • To be scheduled for living donor renal transplantation
  • To have serious life-limiting co-morbid situations, namely active malignancy, active infection, end-stage cardiac, pulmonary, or hepatic disease
  • Pregnancy or lactating
  • Current requirement for HD more than three times per week due to medical comorbidity
  • GFR greater than 10 ml/min/1.73 m2 as measured by the average of urea and creatinine clearances obtained from a urine collection of at least 24 hours
  • Use of temporary catheter
  • Insufficient vascular access (blood flow rate lower than 250 ml/min)
  • Mental incompetence

Treatment and study plan

post-dilution on-line hemodiafiltration

Procedure

post-dilution on-line hemodiafiltration, 3 times a week 4 hours

high flux hemodialysis

Procedure

High-flux hemodialysis, 3 times a week 4 hours

Other names: High-flux hemodialysis

Primary outcomes

  1. composite of overall mortality and new cardiovascular events to include myocardial infarction, stroke, revascularization, and unstable angina pectoris requiring hospitalization.

    Time frame: two years

Secondary outcomes

  1. cardiovascular mortality

    Time frame: two years

  2. hospitalization rate

    Time frame: two years

  3. intradialytic complications including hypotension and cramp

    Time frame: two years

  4. health-related quality of life, depression burden, cognitive function

    Time frame: two years

  5. required medications

    Time frame: two years

  6. changes in blood pressure, left ventricular geometry, arterial stiffness, post-dialysis body weight, upper mid-arm circumference, hematocrit and related rHu-EPO doses, the levels of phosphorus, albumin, lipid parameters, hsCRP, and β-2 microglobulin

    Time frame: two years

  7. postdialysis total body water determined by bioimpedance analysis

    Time frame: two years

Sponsors and collaborators

Lead sponsor

Ercan OK

Other

Collaborators

  • Fresenius Medical Care North America

Registry information

Official study title

Comparison of Post-dilution On-line Hemodiafiltration and Hemodialysis (TURKISH HDF STUDY)

Important dates

Study start
2007
Primary completion
2010
Study completion
2010
First posted
Dec 13, 2006
Registry last updated
Sep 9, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.